• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Pinpointing neurologic dysfunction in fundus photographs using deep learning analysis

Article

Deep learning analysis of fundus photographs has the potential to assess neurologic dysfunction in individuals with Parkinson’s disease.

Doctor holding an image of the brain (Image Credit: AdobeStock/ipuwadol)

(Image Credit: AdobeStock/ipuwadol)

Sangil Ahn, BS, and colleagues reported that deep learning analysis of fundus photographs has the potential to assess neurologic dysfunction in individuals with Parkinson’s disease (PD).1 He is from the Department of Electrical and Computer Engineering, Sungkyunkwan University, Suwon, Republic of Korea.

The ability to assess neurologic disabilities in this manner would eliminate the need for complex neurologic testing by using a noninvasive widely available technology to assess patients, the investigators explained.

In their study, the goal was to develop an algorithm that can predict Hoehn and Yahr (H-Y) scale and Unified Parkinson’s Disease Rating Scale part III (UPDRS-III) scores using fundus photography in patients with PD.

Ahn and colleagues analyzed the fundus photographs of study patients with Parkinson’s disease and participants with atypical motor abnormalities that was not PD who visited the neurology department of Kangbuk Samsung Hospital from October 7, 2020, to April 30, 2021. They developed a convolutional neural network to predict both the H-Y scale and UPDRS-III scores based on fundus photography findings and the participants’ demographic characteristics, they explained.

The study population was comprised of 266 patients with PD (134 men; mean age, 70.8 years), and 349 individuals with non-PD atypical motor abnormalities (236 women; mean age, 70.7 years). The investigators analyzed 539 fundus images from the PD patients.

For the internal validation data set, the sensitivity values were 83.23% (95% confidence interval [CI], 82.07%-84.38%) and 82.61% (95% CI, 81.38%-83.83%) for the H-Y scale and UPDRS-III scores, respectively. The respective specificity values were 66.81% (95% CI, 64.97%-68.65%) and 65.75% (95% CI, 62.56%-68.94%).

For the external validation data set, the sensitivity and specificity were 70.73% (95% CI, 66.30%-75.16%) and 66.66% (95% CI, 50.76%-82.25%), respectively.

The calculated area under the ROC curve and accuracy were 0.67 (95% CI, 0.55-0.79) and 70.45% (95% CI, 66.85%-74.04%), respectively.

The investigators commented, “This decision analytical model reveals amalgamative insights into the neurologic dysfunction among PD patients by providing information on how to apply a deep learning method to evaluate the association between the retina and brain. Study data may help clarify recent research findings regarding dopamine pathologic cascades between the retina and brain among patients with PD; however, further research is needed to expand the clinical implication of this algorithm.”

Reference:
1. Ahn S, Shin J, Song SJ, et al. Neurologic dysfunction assessment in Parkinson disease based on fundus photographs using deep learning. JAMA Ophthalmol. 2023;141(3):234-240. doi:10.1001/jamaophthalmol.2022.5928
Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Dr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced Medication
CIME 2024: Kelsey Roelofs, MD, details collaborative strategies for the management of thyroid eye disease
CIME 2024: Diagnostic tips and treatments for managing Demodex blepharitis
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
© 2024 MJH Life Sciences

All rights reserved.